Biovailability and dosing-schedules of 7-monohydroxy-ethylrutoside, a protector against doxorubicin-induced cardiotoxicity.

F.A.A. van Acker, M.A. Abulhassan, S.A.B.E. van Acker, G.R.M.M. Haenen, A. Bast, W.J.F. van der Vijgh, K. Kramer

    Research output: Contribution to JournalArticleAcademic

    Original languageEnglish
    JournalAnnual Meeting of the American Association for Cancer Research. Proceedings
    Volume40
    Issue number10
    Publication statusPublished - 1999

    Cite this